TFFP Insider Trading Activity and SEC Form 4 Filings
TFFP insider trading summary
No open-market insider purchases or sales of TFF Pharmaceuticals, Inc. (TFFP) have been reported on SEC Form 4 in the past 12 months.
Latest TFFP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 16, 2023 | Asgard Investment Corp. II | 10% Owner | Sell | $392 (1,000 @ $0.39) |
| Aug 16, 2023 | Carlson Capital L P | 10% Owner | Sell | $392 (1,000 @ $0.39) |
| Aug 16, 2023 | Double Black Diamond Offshore Ltd | 10% Owner | Sell | $392 (1,000 @ $0.39) |
| Aug 16, 2023 | Clint Duane Carlson | 10% Owner | Sell | $392 (1,000 @ $0.39) |
| Aug 15, 2023 | Zamaneh Mikhak | Chief Medical Officer | Buy | $30K (120,000 @ $0.25) |
| Aug 15, 2023 | Carlson Capital L P | 10% Owner | Sell | $94K (215,000 @ $0.44) |
| Aug 15, 2023 | Brandi Roberts | Director | Buy | $5K (20,000 @ $0.25) |
| Aug 15, 2023 | Asgard Investment Corp. II | 10% Owner | Sell | $94K (215,000 @ $0.44) |
| Aug 15, 2023 | Kirk Allen Coleman | Chief Financial Officer | Buy | $5K (20,000 @ $0.25) |
| Aug 15, 2023 | Double Black Diamond Offshore Ltd | 10% Owner | Sell | $94K (215,000 @ $0.44) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.